IP Library Granted Patent US 11,202,769
Granted Patent B2
US 11,202,769 · App. 17/130,498 · Granted Dec 21, 2021

Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function

Inventor: Gary Millet (Salt Lake City, UT)
Assignee: AXCESS GLOBAL SCIENCES, LLC
A61K31/22A61K9/0053A61K31/047A61K31/19A23V2200/3322
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,202,769
App. No.
17/130,498
Granted
Dec 21, 2021
Kind
B2
Abstract

Compositions and methods for producing elevated blood levels of ketone bodies and modifying metabolic function in a mammal. Compositions include at least one ester of S-beta-hydroxybutyrate and/or a mono- or di-ester of S-1,3-butanediol and at least one ketone body component. The ketone body component includes beta-hydroxybutyrate, acetoacetate, or both. The beta-hydroxybutyrate is R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, or both. When the ketone body component is S-beta-hydroxybutyrate, the 1,3-butanediol is R-1,3-butanediol, S-1,3-butanediol, or both. Compositions may comprise a keto stack of multiple forms of ketone bodies.

Claims (43)

1. A composition for increasing ketone body level and modify metabolic function in a subject, the composition comprising:

a mono- or di-ester of:

a ketone body component selected from beta-hydroxybutyrate, acetoacetate, or both; and

S-1,3-butanediol; and

at least one ketone body salt selected from the group consisting of beta-hydroxybutyrate salts and acetoacetate salts.

2. The composition of claim 1 , wherein the ketone body component includes R-beta-hydroxybutyrate.

3. The composition of claim 1 , wherein the ketone body component is enriched in R-beta-hydroxybutyrate relative to S-beta-hydroxybutyrate.

4. The composition of claim 1 , wherein the ketone body component includes S-beta-hydroxybutyrate.

5. The composition of claim 1 , wherein the ketone body component is enriched in S-beta-hydroxybutyrate relative to R-beta-hydroxybutyrate.

6. The composition of claim 1 , wherein the composition comprises a di-ester having two beta-hydroxybutyrate compounds bonded to the S-1,3-butanediol.

7. The composition of claim 6 , wherein both of the beta-hydroxybutyrate compounds are R-beta-hydroxybutyrate.

8. The composition of claim 6 , wherein both of the beta-hydroxybutyrate compounds are S-beta-hydroxybutyrate.

9. The composition of claim 6 , wherein one of the beta-hydroxybutyrate compounds is R-beta-hydroxybutyrate and another one is S-beta-hydroxybutyrate.

10. The composition of claim 1 , wherein the composition comprises a di-ester having two acetoacetate compounds bonded to the S-1,3-butanediol.

11. The composition of claim 1 , wherein the composition comprises a di-ester having a beta-hydroxybutyrate and an acetoacetate bonded to the S-1,3-butanediol.

12. The composition of claim 11 , wherein the beta-hydroxybutyrate is R-beta-hydroxybutyrate.

13. The composition of claim 11 , wherein the beta-hydroxybutyrate is S-beta-hydroxybutyrate.

14. The composition of claim 1 , wherein the composition includes a mixture of ketone body components that form the mono- or di-ester such that about 55% to about 95% by weight of ketone bodies of the ketone body component are beta-hydroxybutyrate and about 5% to about 45% by weight are acetoacetate.

15. The composition of claim 1 , wherein the at least one ketone body salt includes at least one of a sodium salt, potassium salt, magnesium salt, calcium salt, amino acid salt, or combination thereof.

16. The composition of claim 1 , further comprising a carrier, the carrier comprising a powder, liquid, gel, suspension, tablet, capsule, food product, food additive, beverage, beverage additive, or food supplement.

17. The composition of claim 1 , further comprising a short or medium chain fatty acid, or a mono-, di- or triglyceride of the short or medium chain fatty acid.

18. A composition for increasing ketone body level and modify metabolic function in a subject, the composition comprising:

a mono- or di-ester of:

S-beta-hydroxybutyrate; and

1,3-butanediol; and

at least one of:

at least one ketone body salt selected from the group consisting of beta-hydroxybutyrate salts and acetoacetate salts, or

at least one ketone body acid selected from the group consisting of beta-hydroxybutyric acid and acetoacetic acid.

19. A stacked composition for increasing ketone body level and modify metabolic function in a subject, the composition comprising:

at least one ester selected from:

an ester of S-beta-hydroxybutyrate; or

an ester of S-1,3-butanediol and at least one ketone body; and

at least one of:

one or more ketone body salts selected from the group consisting of beta-hydroxybutyrate salts and acetoacetate salts, or

one or more ketone body acids selected from the group consisting of beta-hydroxybutyric acid and acetoacetic acid.

20. The composition of claim 18 in a dosage form for oral consumption, wherein the dosage form is selected from the group consisting of powder, liquid, gel, suspension, tablet, capsule, food product, food additive, beverage, beverage additive, and food supplement and provides an oral dose of ketone bodies in a range of about 0.5 gram to about 50 grams.

21. A composition for increasing ketone body level and modifying metabolic function in a subject, the composition comprising:

at least one ester or ester mixture selected from:

an ester of S-beta-hydroxybutyrate or a non-racemic ester mixture enriched in S-beta-hydroxybutyrate relative to R-beta-hydroxybutyrate; or

an ester of S-1,3-butanediol or a non-racemic ester mixture enriched in S-1,3-butanediol relative to R-1,3-butanediol; and

at least one of:

one or more ketone body salts selected from the group consisting of beta-hydroxybutyrate salts and acetoacetate salts, or

one or more ketone body acids selected from the group consisting of beta-hydroxybutyric acid and acetoacetic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2021
From: MILLET, GARY
To: AXCESS GLOBAL SCIENCES, LLC
Reel/Frame 055782/0683 →
Continuity (14)
Continuation In Part 16783886 · Feb 6, 2020
Continuation In Part 16783844 · Feb 6, 2020
Continuation In Part 16409501 · May 10, 2019
Continuation In Part 16381202 · Apr 11, 2019
Continuation In Part 16272192 · Feb 11, 2019
Continuation In Part 16272165 · Feb 11, 2019
Continuation In Part 16224408 · Dec 18, 2018
Continuation In Part 16224485 · Dec 18, 2018
Division 15936849 · Mar 27, 2018
Division 15936820 · Mar 27, 2018
Provisional Application 62659564 · Apr 18, 2018
Provisional Application 62607578 · Dec 19, 2017
Provisional Application 62590063 · Nov 22, 2017
Related Publication 20210169831A1 · Jun 10, 2021
Cited By (15)
US 12,186,297 US 12,251,362 US 12,329,734 US 12,350,243 US 12,433,912 US 12,472,200 US 12,496,283 US 12,514,841 US 12,521,378 US 12,533,331 US 12,533,346 US 12,551,455 US 12,599,579 US 12,622,889 US 12,703,842